We are thrilled to announce that Immuneel Therapeutics, a pioneering clinical stage startup leading the Cell & Gene therapy revolution in India, has successfully raised $12,000,000 in funding. This significant investment will enable Immuneel Therapeutics to continue their vital work in bringing breakthrough cancer treatments to patients in India, with a focus on making these innovative therapies more accessible and affordable. The company's dedication to transforming the landscape of cancer treatment through cutting-edge technology and innovative approaches has garnered widespread attention and support, and this latest round of funding will undoubtedly propel them even further towards their mission of revolutionizing cancer care and improving patient outcomes. With this new funding in place, Immuneel Therapeutics is poised to make a lasting impact on the field of oncology and pave the way for a brighter future for cancer patients in India and beyond.
Immuneel Therapeutics Secures $12 Million in Series A Funding to Advance Revolutionary Cancer Treatments in India
Recently funded · $12.0M Series aHealthcare
Get the full Immuneel Therapeutics company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
Other recent Series a rounds
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Aligned Marketplace | Series a | $20.0M | today |
| 2 |  Vals AI United States | Series a | $40.0M | today |
| 3 |
.png&w=3840&q=75)
